Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

EVO | Evotec SE

Healthcare | Drug Manufacturers - Specialty & Generic | Germany | NASD

Index	-	P/E	-	EPS (ttm)	-0.32	Insider Own	-	Shs Outstand	354.37M	Perf Week	-16.72%
Market Cap	3.58B	Forward P/E	37.81	EPS next Y	0.27	Insider Trans	-	Shs Float	354.37M	Perf Month	-7.77%
Income	-	PEG	-	EPS next Q	-0.05	Inst Own	0.39%	Short Float / Ratio	0.01% / 0.87	Perf Quarter	-8.88%
Sales	-	P/S	-	EPS this Y	65.40%	Inst Trans	-	Short Interest	0.02M	Perf Half Y	5.37%
Book/sh	-	P/B	-	EPS next Y	250.00%	ROA	-	Target Price	17.60	Perf Year	8.39%
Cash/sh	-	P/C	-	EPS next 5Y	-	ROE	-	52W Range	7.80 - 13.49	Perf YTD	26.21%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-	52W High	-24.33%	Beta	1.32
Dividend %	-	Quick Ratio	-	Sales past 5Y	-	Gross Margin	-	52W Low	30.90%	ATR	0.44
Employees	5067	Current Ratio	-	Sales Q/Q	-1.10%	Oper. Margin	-	RSI (14)	30.75	Volatility	3.72% 2.86%
Optionable	No	Debt/Eq	-	EPS Q/Q	-	Profit Margin	-	Rel Volume	4.73	Prev Close	11.50
Shortable	Yes	LT Debt/Eq	-	Earnings	Aug 29 BMO	Payout	-	Avg Volume	26.08K	Price	10.21
Recom	2.00	SMA20	-12.58%	SMA50	-15.24%	SMA200	-2.32%	Volume	123,476	Change	-11.22%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-23-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$12 → $16
Jun-16-23	Downgrade	BofA Securities	Buy → Neutral	$13
Jun-08-23	Upgrade	Citigroup	Neutral → Buy
Apr-04-23	Upgrade	Morgan Stanley	Underweight → Equal-Weight	$11 → $12
Dec-09-22	Initiated	H.C. Wainwright	Buy	$12
Nov-16-22	Downgrade	Deutsche Bank	Buy → Hold
Aug-10-22	Downgrade	Morgan Stanley	Overweight → Underweight	$23 → $16
Mar-02-22	Resumed	Cowen	Outperform
Jan-07-22	Resumed	Citigroup	Neutral

Aug-29-23 01:20AM	Evotec SE Reports Results for the First Half-year 2023 and Provides Corporate Updates (ACCESSWIRE) +5.68%
Aug-22-23 08:20AM	Evotec SE Reports First Half-Year 2023 Results on 29 August 2023 (ACCESSWIRE)
Jul-27-23 02:45PM	Evotec Provides Update on Financial Impact of Cyber-Attack (ACCESSWIRE) -8.83%
02:05PM	Evotec Provides Update on Financial Impact of Cyber-Attack (ACCESSWIRE)
Jul-11-23 08:00AM	The Accountant Shortage Is Showing Up in Financial Statements (The Wall Street Journal) +5.03%
01:50AM	Loading…
01:50AM	Evotec and Bristol Myers Squibb Enter Licence Agreement within Neuroscience Partnership (ACCESSWIRE)
Jul-05-23 01:50AM	Just - Evotec Biologics Awarded Second Contract from U.S. Department of Defense Under Accelerated Antibodies Program (ACCESSWIRE)
Jun-29-23 02:00AM	Evotec Receives Milestone Payment for First Patient Dosed in Phase I Study of Bayer Kidney Disease Programme (ACCESSWIRE)
Jun-20-23 11:30AM	Evotec SE Annual General Meeting 2023 Approves All Proposed Agenda Items (ACCESSWIRE)
Jun-05-23 01:50AM	Evotec Presents Sustainability Strategy (ACCESSWIRE)
Jun-02-23 02:00AM	Evotec Receives Grant from Open Philanthropy for Discovery of RNA-Targeting Henipavirus Therapeutics (ACCESSWIRE)
May-12-23 06:30PM	Evotec publishes Annual Report 2022 and Quarterly Statement for Q1 2023 (ACCESSWIRE)
May-09-23 02:55PM	Just - Evotec Biologics Enters Strategic Biosimilars Partnership with Sandoz (ACCESSWIRE)
02:30PM	Just - Evotec Biologics Launches Tech Partnership for Biosimilars Development and Commercial Manufacturing (ACCESSWIRE)
Apr-24-23 04:05PM	Successful Results Using Sernovas Cell Pouch System with Evotecs iPSC-Derived Islet-like Clusters for Type 1 Diabetes Presented at the 4th IPITA / HSCI / JDRF Summit (GlobeNewswire)
08:15AM	Loading…
Apr-10-23 08:15AM	Evotec SE Provides Update on Cyber Attack (ACCESSWIRE)
Apr-07-23 09:20AM	Cyber Attack on Evotec (ACCESSWIRE)
Mar-28-23 05:20AM	Evotec and Bristol Myers Squibb Extend and Expand Strategic Neurodegeneration Partnership (ACCESSWIRE) +5.19%
01:30AM	Evotec SE Preliminary Fiscal Year 2022 Results: 'Ahead of the Curve' - Very Strong Performance in a Challenging Year (ACCESSWIRE)
Mar-24-23 03:00AM	Evotec Receives US$ 6.6 m Grant for Drug Discovery in Tuberculosis (ACCESSWIRE)
Mar-21-23 07:10AM	Evotec SE to Announce Preliminary Financial Results for Fiscal Year 2022 on 28 March 2023 (ACCESSWIRE)
Mar-16-23 03:05AM	Evotec Announces Progress in Strategic Protein Degradation Partnership with Bristol Myers Squibb (ACCESSWIRE) +6.72%
Feb-10-23 02:00AM	Evotec Receives 150 m Loan from European Investment Bank (ACCESSWIRE)
Feb-09-23 02:00AM	Evotec and Related Sciences Expand Integrated Drug Discovery and Development Partnership (ACCESSWIRE)
Feb-07-23 02:00AM	Evotec SE: Laetitia Rouxel to succeed Enno Spillner as Chief Financial Officer (ACCESSWIRE)
Jan-26-23 02:00AM	Evotec Announces Agreement with Janssen to Develop Immune-Based Therapies (ACCESSWIRE) +7.48%
Jan-10-23 07:00AM	Sernova and Evotec on Track to Initiate Clinical Testing of the First iPSC-Derived Islets in Cell Pouch as a Potential Functional Cure for Type 1 Diabetes (GlobeNewswire)
Dec-16-22 03:40AM	Evotec Achieves Further Progress in Neuroscience Collaboration with Bristol Myers Squibb (ACCESSWIRE)
Nov-12-22 01:32AM	Earnings Miss: Evotec SE Missed EPS And Analysts Are Revising Their Forecasts (Simply Wall St.)
Nov-10-22 11:51PM	Evotec Third Quarter 2022 Earnings: Misses Expectations (Simply Wall St.) +9.72%
08:00AM	Loading…
Nov-09-22 08:00AM	Edited Transcript of EVTG.DE earnings conference call or presentation 9-Nov-22 1:00pm GMT (Thomson Reuters StreetEvents) -10.39%
01:20AM	Evotec SE Reports Results for the First Nine Months 2022 and Provides Corporate Update (ACCESSWIRE)
Nov-08-22 11:02PM	Evotec falls as U.K. writedown, expansion costs drive 9-month loss (Investing.com)
03:07AM	Investors in Evotec (ETR:EVT) have unfortunately lost 53% over the last year (Simply Wall St.)
Nov-03-22 07:15AM	Evotec SE to Announce Results for the First Nine Months 2022 on 09 November 2022 (ACCESSWIRE) -5.65%
03:00AM	Evotec Completes Acquisition of Central Glass Germany (ACCESSWIRE)
Nov-02-22 03:00AM	Evotec Presents Paradigm Shift in Biologics at Capital Markets Day (ACCESSWIRE)
Oct-28-22 03:20AM	Evotec, CDP Venture Capital and Angelini Ventures Launch Translational Partnership 'Extend' with Leading Italian Academic Institutions (ACCESSWIRE)
Oct-25-22 01:50AM	Evotec Enters Partnership with Hannover Medical School to Create Molecular Patient Database in Autoimmune Diseases (ACCESSWIRE) +6.54%
Oct-18-22 09:03AM	10 Best Low Price Pharma Stocks To Buy Now (Insider Monkey)
02:00AM	Evotec launches PanOmics Data Analysis Platform PanHunter at Bio-IT World (ACCESSWIRE)
Oct-17-22 07:15AM	Evotec and TIAP Expand LAB150 BRIDGE Partnership to Include Amgen (ACCESSWIRE) +5.54%
07:00AM	TIAP and Evotec Expand LAB150 BRIDGE Partnership to Include Amgen (Business Wire)
Sep-21-22 10:06AM	Adapsyn Bioscience Inks Collaboration Pact With Evotec (Benzinga)
Sep-20-22 01:50AM	Just Evotec Biologics Awarded Contract from the U.S. Department of Defense Under Accelerated Antibodies Program (ACCESSWIRE) -5.71%
Sep-16-22 09:25AM	Evotec Initiates Ground-Breaking for New Biologics Facility J.POD(R) Toulouse, France (EU) (ACCESSWIRE)
Sep-01-22 07:33AM	Sernova Receives Second Tranche Equity Investment from Evotec of $6.8 Million at a Price of $2.50 Per Share (GlobeNewswire)
Aug-25-22 01:50AM	Evotec Expands Clinical and Commercial Drug Substance Manufacturing with Acquisition of Central Glass Germany (ACCESSWIRE)
Aug-11-22 01:40AM	Evotec SE Reports Results for the First Half-year 2022 and Provides Corporate Updates (ACCESSWIRE)
Aug-10-22 07:54AM	Evotec, Alpine Expand Pact For Commercial Process Development Of Autoimmune Disease Candidate (Benzinga) -7.08%
01:55AM	Just - Evotec Biologics and Alpine Immune Sciences Expand Partnership for Commercial Process Development of ALPN-303 (ACCESSWIRE)
01:30AM	Just Evotec Biologics and Alpine Immune Sciences Expand Partnership for Commercial Process Development of ALPN-303 (Business Wire)
Aug-04-22 05:30AM	Evotec SE Reports First Half-year 2022 Results on 11 August 2022 (ACCESSWIRE)
Jul-06-22 01:50AM	Evotec, Boehringer Ingelheim, and bioMérieux Launch Aurobac, a Joint Venture to Fight Antimicrobial Resistance (ACCESSWIRE)
Jul-05-22 01:50AM	Evotec Completes Acquisition of Rigenerand (ACCESSWIRE)
Jun-22-22 10:45AM	Evotec SE Reports Results of Annual General Meeting 2022 (ACCESSWIRE)
Jun-15-22 10:47AM	Evotec (EVO) Inks Drug Discovery Collaboration Deal With J&J (Zacks)
Jun-14-22 10:23AM	Exscientia -Evotec Cancer Therapy Shows Encouraging Action In Healthy Volunteers (Benzinga)
01:50AM	Evotec Enters a Drug Discovery Collaboration with Janssen (ACCESSWIRE)
May-30-22 02:00AM	Evotec Adds Cell Therapy Manufacturing Facility with Acquisition of Rigenerand (ACCESSWIRE)
May-19-22 01:50AM	Evotec and Almirall Enter into a Multi-Target Alliance in Medical Dermatology (ACCESSWIRE) +5.49%
May-17-22 11:33AM	Sernova, Evotec Join Forces To Develop 'Functional Cure' For Diabetes (Benzinga)
07:00AM	Sernova and Evotec Enter into an Exclusive Global Strategic Partnership for iPSC-Based Beta Cell Replacement Therapy to Develop and Commercialize a Functional Cure for Diabetes (GlobeNewswire)
01:50AM	Evotec and Sernova Announce Exclusive Strategic Partnership for iPSC-based Beta Cell Replacement Therapy to Advance a 'Functional Cure' for Diabetes (ACCESSWIRE)
May-10-22 10:55AM	Evotec and Bristol Myers Squibb Extend and Expand Strategic Partnership (ACCESSWIRE) +16.42%
10:45AM	Evotec and Bristol Myers Squibb Extend and Expand Strategic Partnership in Protein Degradation (ACCESSWIRE)
May-04-22 08:45AM	Evotec SE to Announce Results for the First Quarter 2022 on 11 May 2022 (ACCESSWIRE)
Apr-25-22 04:03PM	Insider Selling at Snap (NYSE:SNAP) Shows no Signs of Slowing Down (Simply Wall St.)
11:47AM	Copycatting TikTok is a big trend, analyst says after Snap earnings (Yahoo Finance)
Apr-22-22 09:23AM	Snap posts earnings loss in Q1 following Apple ad changes (Yahoo Finance Video)
Apr-12-22 01:45AM	Evotec SE Fiscal Year 2021 Results: 'Setting the Pace' on the Data-Driven R&D Autobahn to Cures (ACCESSWIRE) -7.21%
Apr-08-22 01:55AM	Evotec Achieves Programme Designation in Neuroscience Collaboration with Bristol Myers Squibb (ACCESSWIRE)
Apr-05-22 08:55AM	Evotec SE to Announce Results for Fiscal Year 2021 on 12 April 2022 (ACCESSWIRE)
Apr-04-22 11:44AM	Evolution goes live on day one of Ontario online gaming market with multiple operators (PR Newswire)
Mar-21-22 03:00AM	Evotec Receives 3 m Milestone Payment for Bayer Starting Phase II Clinical Development of DNP Programme (ACCESSWIRE)
Mar-02-22 01:50AM	Evotec Presents Strategic Roadmap Towards Precision Medicine and Confirms Goals of Action Plan 2025 at Capital Markets Day (ACCESSWIRE)
Mar-01-22 01:50AM	Evotec Expands Molecular Patient Database with Unique Nephrotic Syndrome Cohort from the University of Bristol (ACCESSWIRE)
Feb-04-22 02:44PM	Why Are Evotec Shares Trading Lower On Friday? (Benzinga) -15.07%
07:45AM	Bayer Discontinues Clinical Development Candidate Eliapixant (BAY1817080), Evotec Regains the Rights to all P2X3 Assets (ACCESSWIRE)
Jan-25-22 01:55AM	Evotec Enters iPSC-based Drug Discovery Partnership with Boehringer Ingelheim in Ophthalmology (ACCESSWIRE)
Jan-18-22 03:53AM	Germany's Evotec partners with Lilly to research metabolic diseases (Reuters)
02:00AM	Evotec and Lilly Enter into Drug Discovery Collaboration in Metabolic Diseases (ACCESSWIRE)
Jan-11-22 02:00AM	Evotec Expands Neuroscience Collaboration with Bristol Myers Squibb to Include New Targeted Protein Degradation Approach (ACCESSWIRE)
Jan-03-22 01:55AM	Evotec Receives 7.5 m Grant for Development of COVID-19 Therapeutic (ACCESSWIRE)
Dec-24-21 11:38AM	Putnam VT Emerging Markets Equity Fund Buys Aspeed Technology Inc, ICICI Bank, Contemporary ... (GuruFocus.com)
01:38AM	Global Insight Portfolio Buys Bill.com Holdings Inc, Cazoo Group, Roblox Corp, Sells Spotify ... (GuruFocus.com)
Dec-16-21 02:00AM	Evotec Receives US$ 18 M Grant for Women's Health (ACCESSWIRE) -5.02%
Dec-15-21 10:38AM	VIP International Capital Appreciation Portfolio Buys Essilorluxottica, RELX PLC, Dassault ... (GuruFocus.com) +7.77%
Nov-18-21 07:00AM	EQRx and Evotec Announce Integrated Drug Discovery and Development Partnership (Business Wire)
01:50AM	Evotec and EQRx Announce Integrated Drug Discovery and Development Partnership (ACCESSWIRE)
Nov-11-21 01:30AM	Evotec SE Reports Results for the First Nine Months 2021 and Provides Corporate Update (ACCESSWIRE)
Nov-10-21 02:00AM	Evotec Reaches Programme Designations in Neuroscience Collaboration with Bristol Myers Squibb (ACCESSWIRE)
Nov-09-21 09:55AM	Evotec SE Announces Closing of Public Offering (ACCESSWIRE)

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare diseases, respiratory diseases, and women's health. It has collaboration agreements with Bayer; Lilly; Almirall; Chinook Therapeutics; Novo Nordisk A/S; Galapagos; Pfizer Inc.; CONBA Pharmaceutical Co., Ltd.; Bristol Myers Squibb Company; Zhejiang JingXin Pharmaceutical Co., Ltd; Janseen Biotech; Kazia Therapeutics; Apeiron Biologics; and Takeda Pharmaceuticals. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

EVO | Evotec SE

Upgrade your FINVIZ experience